Physician profile
Clare E Farrell
NPI 1710252069
$1,359.29
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2021: $445 · 2022: $319 · 2023: $410 · 2024: $24.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.43 | 2021-2024 | |
| Novo Nordisk INC | $347.64 | 2021-2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.77 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $53.09 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $43.96 | 2019 | |
| Exact Sciences Corporation | $35.68 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $30.46 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.40 | 2022 | |
| Idorsia Pharmaceuticals US INC | $19.20 | 2023 | Quviviq |
| Shire North American Group INC | $18.56 | 2019 | |
| Pfizer INC. | $18.43 | 2023 | |
| Paratek Pharmaceuticals, INC. | $18.37 | 2022 | |
| Lilly USA, LLC | $18.34 | 2023 | Mounjaro |
| Glaxosmithkline, LLC. | $18.29 | 2021 | |
| Sanofi Pasteur INC. | $16.12 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.95 | 2021 | |
| Virtus Pharmaceuticals LLC | $13.57 | 2021 | |
| Valeritas, INC. | $12.80 | 2019 | |
| Abbott Laboratories | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clare Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.